Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AIM Health Group was a Canadian healthcare services provider that specialized in the management of chronic diseases through a network of infusion clinics, pharmacies, and medical centers. The company focused on providing community-based care for patients requiring complex drug therapies, particularly in the fields of pain management and specialty biologics. In 2012, AIM Health Group was acquired by McKesson Canada, a move that significantly expanded McKesson's specialty health services and patient support programs. The company's infrastructure was integrated into McKesson's clinical network, continuing to serve patients across Canada under the parent organization's umbrella. Prior to its acquisition, the company was publicly traded on the Toronto Stock Exchange under the symbol AHG.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AIM Health Group.